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Abstract
Objective
It is an accepted fact that confinement conditions increase the risk of some infections
related to sexual and/or injecting drugs practices. Mathematical techniques were applied
to estimate time-dependent incidence densities of HIV infection among inmates.
Methods
A total of 631 prisoners from a Brazilian prison with 4,900 inmates at that time
were interviewed and their blood drawn. Risky behavior for HIV infection was
analyzed, and serological tests for HIV, hepatitis C and syphilis were performed,
intended as surrogates for parenteral and sexual HIV transmission, respectively.
Mathematical techniques were used to estimate the incidence density ratio, as related
to the time of imprisonment.
Results
Prevalence were: HIV – 16%; HCV – 34%; and syphilis – 18%. The main risk
behaviors related to HIV infection were HCV prevalence (OR=10.49) and the
acknowledged use of injecting drugs (OR=3.36). Incidence density ratio derivation
showed that the risk of acquiring HIV infection increases with the time of
imprisonment, peaking around three years after incarceration.
Conclusions
The correlation between HIV and HCV seroprevalence and the results of the
mathematical analysis suggest that HIV transmission in this population is
predominantly due to parenteral exposure by injecting drug, and that it increases
with time of imprisonment.
Resumo
Objetivo
É um fato correntemente aceito que as condições de confinamento aumentam o
risco de algumas infecções relacionadas às práticas sexuais e/ou ao uso de drogas
injetáveis. Realizou-se estudo para estimar a densidade de incidência da infecção
pelo HIV na população prisional com aplicação de técnicas matemáticas.
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Métodos
Foram entrevistados em São Paulo, SP, 631 prisioneiros da maior prisão da América do
Sul, que abrigava aproximadamente 4.900 presos na ocasião do estudo. Foi colhido
sangue da população entrevistada, analisado o risco para a infecção pelo HIV e realizados
testes sorológicos para HIV, HCV e sífilis. Técnicas matemáticas foram usadas para se
estimar a densidade de incidência do HIV relacionada ao tempo de encarceramento.
Resultados
As prevalências gerais encontradas foram: HIV – 16%; HCV – 34%; sífilis – 18%.
Os principais fatores associados à infecção pelo HIV foram a soropositividade ao
HCV (OR=10,49) e a confissão do uso de drogas injetáveis (OR=3,36). A análise
matemática mostrou que o risco de adquirir a infecção pelo HIV aumenta com o
tempo de detenção, atingindo o máximo por volta de 3 anos de aprisionamento.
Conclusões
A correlação entre a soroprevalência do HIV e do HCV e os resultados da análise
matemática sugerem que a transmissão do HIV nestsa população se dá preferencialmente
pela via parenteral e que seu risco aumenta com o tempo de encarceramento.
INTRODUCTION
It is accepted that confinement conditions increase the
risk of some infections related to sexual and/or injecting
drug practices. In addition to confinement, other risk
factors like marginal social status, drug addiction, low
socioeconomic level and precarious health services con-
tribute to the observed high prevalence of HIV, hepati-
tis, syphilis and tuberculosis, to name a few. This repre-
sents a potential public health problem in the sense that
penal system acts as a concentrator of those infections
and as a spreading focus for the population at large.11,18,22
Several works have reported high levels of HIV
seroprevalence in prison institutions.11,19,22 In Brazil, a
study carried out in 1987 found an HIV seroprevalence
of 12.5% among inmates.15 Another survey demon-
strated a seroprevalence of 14.9% in 1990 and 17.3%
in 1991.7 In a more recent study, there was an HIV
seroprevalence of 15.6% in a sample of prisoners from
São Paulo State.11In addition to the high prevalence of
HIV among recent admitted individuals, it is well-
known that in some prisons risk behavior for HIV in-
fection can be very high.14,16 A number of studies con-
ducted in the United States and elsewhere have found
that a substantial proportion of prisoners engage in high-
risk sexual activity and/or intravenous drug use while
in prison.14,16,17 In a recent Scottish study5 it was dem-
onstrated that 27% of the inmates reported injecting
drug usage any time in life. Of those, 59% admitted
using it inside the prison, of which a quarter had their
first experience with injecting drugs in prison.
Notwithstanding, one significant obstacle in plan-
ning control strategies against HIV spread is the lack
of reliable markers of the route of HIV transmission.
Most studies rely on interviews based on standard
questionnaires,14,17,21 which are limited tools for as-
sessing patterns of transmission in the sense that a
great number of individuals report both parenteral and
sexual exposure practices. On the other hand, in par-
ticular situations, like imprisonment, it should be ex-
pected that individuals conceal, due to fear of legal
consequences, the use of illicit drugs.
To circumvent such limitations, hepatitis C and
syphilis seroprevalence were used in this study as
surrogates2,11,18 of parenteral and sexual transmission
of HIV, respectively, besides the classical question-
naires of risky behavior.
There have been also some concern in the literature
about the possibility and/or importance of the occur-
rence of HIV transmission inside prisons, but there
are still few studies and the majority of them pro-
vides only indirect evidence of in-prison HIV trans-
mission.13,19 Mutter et al13 carried out a seroprevalence
survey in 87 inmates before 1977. They found a
positivity of 21%, indicating a likely HIV transmis-
sion inside the penal system.
Mathematical techniques were applied to estimate
time-dependent incidence densities of HIV infection
among inmates. The analysis was based upon the re-
sults of a cross-sectional survey carried out in a sam-
ple of 631 prisoners of a major penitentiary institu-
tion of São Paulo, who were interviewed and their
blood drawn for determining the seroprevalences of
HIV, hepatitis C and syphilis.11,18
METHODS
A detailed description of the clinical and epidemio-
logical findings of this study can be found in the pa-
per by Massad et al.11 Follows a brief description of
the study for the sake of completeness only.
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The target population
This work was carried out in one of the prisons of
the largest penal institution of Latin America (10,000
prisoners), the so-called “Casa de Detenção”
(Detention House, DH). Although this is supposed to
be a transitory step for those individuals who are
waiting for a final judicial decision, they stay in fact
for several years in this institution.
The sampling method
The sample was selected by drawing the numbered
individual prison files in intervals determined by a
random number generator. In addition, there were
included all inmates admitted to the institution during
the two weeks period of the study. Participation in
the study was voluntary and confidentiality was
guaranteed. The sample size was determined based
on an expected seroprevalence to HIV (P+) of 15%,
with specified relative precision (ε) of 20% and
confidence level (α) of 95% according to:8,11
which, after correction for a finite population and
assuming 20% of refusal,  resulted in 670
individuals. Thirty-seven individuals refused to
participate in the study, so only 631 inmates were
available for analysis.
The fieldwork
The inmates were interviewed, clinically examined
and their blood drawn for serological examination.
The fieldwork took place from December 1993 to
April 1994. The interview consisted of answering a
standard questionnaire including specific questions
relative to their imprisonment history and HIV-related
risk behavior, besides clinical aspects related to HIV/
AIDS infection.11 The interviews were conducted by
physicians.
Laboratory tests
Serological examinations for HIV and hepatitis C
were performed by standard ELISA techniques with
commercial kits from Embrabio and Abbot
Diagnostics Division (second generation kit),
respectively. Syphilis was screened by standard TPHA
technique with the Bio-Mérieux commercial kit.
Those tests with a positive ELISA reaction to HIV
were confirmed by Western Blot technique, using
commercial kit by Diagnostic Pasteur.
Data analysis
The association between risk behavior and HIV
infection was evaluated by multivariate analysis using
logistic regression, and its details are described
elsewhere.11 The fitting of the prevalence curves of
the infections studied in the period of time since
admission at DH, t, was performed by the least-square
method, applying the software Tablecurve,6 resulting
in third order logistics (hepatitis C and HIV) and
straight line (syphilis).
To estimate the occurrence of HIV transmission
inside the prison, HIV incidence was calculated from
prevalence data. This is done by applying the so-called
catalytic approach as described below. First, however,
the observed prevalence of HIV has to be corrected
by taking into account the prevalence at entry at
different times of imprisonment and the AIDS-specific
mortality in the last 15 years.
The prevalence at admission, Pentry, for the inmates
who had been imprisoned 13, 6, 4 and 2 years before
the study,7,15 and that estimated in our study11 were
fitted to a continuous function. Expected prevalence
of HIV as related to the time of imprisonment were
also corrected by the estimated number of deaths due
to HIV, αHIV,
 
during the same period of time. The
latter was based on records from the DH’s health
service. The correction consisted in the following:
p
adjusted (t)= pobserved (t)+ αHIV (t)  - pentry (t)
The catalytic approach9,12 was applied to estimate
the time-dependent force of infection (λ) for HIV
among the inmates, according to the formula:
where P+(t) is the continuous function represent-
ing the adjusted prevalence of the infection consid-
ered. The force of infection corresponds to the inci-
dence density ratio of the disease, and represents the
per capita rate of acquisition of new infection. In
this sense it reflects the time-dependent risk of get-
ting the infection.
RESULTS
Between the months of December 1993 and April
1994, 631 inmates were interviewed, clinically ex-
amined and their blood drawn for serological exami-
nation. Their average age was 30.8 years (median 29
years), and 35% of them had been incarcerated for at
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least 2 years before admission at DH. The average
time of imprisonment in DH was 2.8 years. Overall
prevalence found were as follows: HIV – 16% (95%
CI: 13-19%); HCV – 34% (95% CI: 30-38%); syphi-
lis – 18% (95% CI: 15-21%). The undetermined re-
actions on Western-Blot and immunoblot were con-
sidered negative to HIV and HCV respectively, for
the purposes of the risk analysis. Table resumes the
results of the risk analysis to HIV infection. Its re-
sults are presented in detail elsewhere.11
Table – Risk analysis to HIV infection among inmates of
Detention House.
Risk factor OR (CI-95%) Adjusted OR (CI-95%)
                                           (bivariate analysis)(multivariate analysis)
Injecting drug use 8.2(5.0-13.3) 3.36(1.82-6.21)
Homo/bisexual behaviour 2.7(1.5-4.8) 2.41(1.07-5.43)
Heterosexual risk behaviour 1.6(1.01-2.5) 1.64(0.93-2.92)
Anti-HCV positivity 15.4(8.5-27.9) 10.49(5.06-21.72)
TPHA positivity 1.3(0.8-2.4) 1.57(0.79-3.12)
The first three variables presented in Table were
assessed through a standardized questionnaire and
represent the acknowledged behavior of the inmates.
On the other hand, the last two variables were obtained
by serological testing and therefore are less prone to
uncertainties.
Figure 1 shows the fitting of the seroprevalences of
HIV, HCV and syphilis among inmates, as related to
their time of imprisonment. It is noteworthy the striking
parallelism between the HIV and HCV curves.
It can be noted from Figure 1 that HIV and HCV
seroprevalences are highly correlated (r=0.98). On the
other hand, the correlation between HIV and syphilis
seroprevalences is rather poor (r=0.25).
In Figure 2 it is shown the fitting of HIV
seroprevalence to a continuous function, P+(t), as
related to the time of imprisonment. It was
simultaneously corrected by the expected prevalence
at admission at DH in the last decade and by the
estimated number of deaths due to HIV during the
same period of time, as mentioned above. The
resultant force of infection to HIV was then calculated
according to equation (1) and is shown in Figure 3.
DISCUSSION
The prison population is markedly characterized by
high-risk behavior for the acquisition of sexual
transmitted disease (STD) and blood borne infection.
Those risky habits are present before and most
probably continue after imprisonment. Therefore,
suitable techniques for the detection of transmission
inside prison are necessary. In this sense, mathematical
methods applied to cross-sectional serological surveys
to estimate incidence rate have already demonstrated
to be a good alternative to cohort studies.1,9
Another crucial issue is to determine the main route
of HIV transmission in populations exposed to both
sexual and parenteral risks. This is particularly true for
confined populations for which control strategies can
be applied and should be optimized. The use of
serological markers of infections acknowledgeable
parenterally or sexually transmitted as surrogates for
determining the actual route of HIV transmission seems
to be a reasonable choice. Hepatitis C and syphilis
seroprevalence were chosen as markers for parenteral
and sexual transmission of HIV, respectively. This
Figure 3 - Time-dependent HIV force of infection, l(t),
calculated according to equation 1 as applied to the corrected
seroprevalence curve (Figure 5).
Figure 2 - Fitting of HIV seroprevalence to a continuous
function, P(t), after simultaneously adjusting for the prevalence
at entry and the expected number of deaths due to AIDS in the
last decade.
Figure 1- Fitting of the seroprevalences of HIV, HCV and
Syphilis to real data, as related to the time (in years) since
imprisonment.
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choice is based on the assumption that those infections
are mostly transmitted by one predominant route,
making the alternative route negligible for population
screening purposes. This assumption, although not
indisputable, has sufficient support in the literature.3,20
In addition, it was already tested the suitability of such
markers as surrogates of the HIV route of
transmission.2,11,22
As pointed before, the use of mathematical
techniques to estimate incidence rates from cross-
sectional prevalence data has already proved to be
reliable enough for epidemiological purposes.1,9 They
can also be used to provide good estimations of the
intensity of HIV transmission based upon information
collected through risk behavior questionnaires.10
The use of such techniques raised the suspicion of
active HIV transmission inside the prison. As shown
in Figure 3, the incidence rate of HIV (measured as
the average number of HIV seroconversion per sus-
ceptible individual per year) increases with time of
imprisonment, reaching its maximum around 3 years.
This finding reflects the growth in time of HIV
seroprevalence, after correction by the expected preva-
lence at entry to DH in previous years. Time-depend-
ent seroprevalence curve was also corrected by the
expected mortality due to AIDS in recent years. The
latter was necessary because otherwise HIV preva-
lence of the inmates would be underestimated with
more than 5 years of imprisonment. Recently, there
was an opportunity to check the accuracy of these
estimates since a parallel sample (surveyed one month
before the present study) of the same prison have been
tested for HIV by a less-sensitive ELISA, which al-
lows the estimation of the prevalence of recent
seroconversions.4 The findings of such study also
pointed to an incidence of HIV inside DH peaking
around 3.5 years after imprisonment.
Finally, some limitations of this study should be
mentioned, such as the assumptions related to the
corrections for deaths and prevalence at admission.
However, the present results are encouraging in
reinforcing cross-sectional seroprevalence surveys as
a means to determine incidence rates. Moreover, by
applying such techniques it was able to demonstrate
the importance of active HIV transmission inside the
prison studied, and that intravenous drug use is the
likely route of transmission in this penal institution.
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